Publications by authors named "Nicholas B Jennings"

Claim this Profile
E
Epigenetic modulation of BARD1 to enhance anti-VEGF therapy.
Emine Bayraktar, Cristian Rodriguez-Aguayo, Elaine Stur, Sudhir Kumar, Lingegowda S Mangala, Nicholas B Jennings

Cell Rep Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism and rational combinations with GP-2250, a novel oxathiazine derivative, in ovarian cancer.
Mark S Kim, Deanna Glassman, Katelyn F Handley, Adrian Lankenau Ahumada, Nicholas B Jennings

Cancer Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing oral delivery of plant-derived vesicles for colitis.
Yuan Liu, Adrian Lankenau Ahumada, Emine Bayraktar, Paul Schwartz, Mamur Chowdhury, Nicholas B Jennings

J Control Release· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L.
Christopher J LaFargue, Paola Amero, Kyunghee Noh, Lingegowda S Mangala, Yunfei Wen, Nicholas B Jennings

Nat Commun· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial p130cas confers resistance to anti-angiogenesis therapy.
Yunfei Wen, Anca Chelariu-Raicu, Sujanitha Umamaheswaran, Alpa M Nick, Elaine Stur, Nicholas B Jennings

Cell Rep· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Profiles of Serum-Derived Extracellular Vesicles in High-Grade Serous Ovarian Cancer.
Li Zhao, Sara Corvigno, Shaolin Ma, Joseph Celestino, Nicole D Fleming, Nicholas B Jennings

Cancers (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial p130cas confers resistance to anti-angiogenesis therapy.
Yunfei Wen, Anca Chelariu-Raicu, Sujanitha Umamaheswaran, Alpa M Nick, Elaine Stur, Nicholas B Jennings

Cell Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CCR2 macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer.
Yutuan Wu, Nicholas B Jennings, Yunjie Sun, Santosh K Dasari, Emine Bayraktar

J Cancer Res Clin Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
Lingegowda S Mangala, Cristian Rodriguez-Aguayo, Emine Bayraktar, Nicholas B Jennings, Gabriel Lopez-Berestein

Methods Mol Biol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial p130cas confers resistance to anti-angiogenesis therapy.
Yunfei Wen, Anca Chelariu-Raicu, Sujanitha Umamaheswaran, Alpa M Nick, Elaine Stur, Nicholas B Jennings

Cell Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune microenvironment composition in high-grade serous ovarian cancers based on BRCA mutational status.
Sara Corvigno, Jared K Burks, Wei Hu, Yanping Zhong, Nicholas B Jennings

J Cancer Res Clin Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.
Premal H Thaker, Liz Y Han, Aparna A Kamat, Jesusa M Arevalo, Rie Takahashi, Nicholas B Jennings

Nat Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancer.
Yutuan Wu, Jie Huang, Cristina Ivan, Yunjie Sun, Shaolin Ma, Nicholas B Jennings

Gynecol Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's Note: Biologic Effects of Platelet-Derived Growth Factor Receptor α Blockade in Uterine Cancer.
Ju-Won Roh, Jie Huang, Wei Hu, XiaoYun Yang, Nicholas B Jennings

Clin Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's Note: Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
Lingegowda S Mangala, Vesna Zuzel, Rosemarie Schmandt, Erik S Leshane, Jyotsna B Halder, Nicholas B Jennings

Clin Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance.
Shaolin Ma, Lingegowda S Mangala, Wen Hu, Emine Bayaktar, Akira Yokoi, Nicholas B Jennings

Cell Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATP11B mediates platinum resistance in ovarian cancer.
Myrthala Moreno-Smith, J B Halder, Paul S Meltzer, Tamas A Gonda, Lingegowda S Mangala, Nicholas B Jennings

J Clin Invest· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens.
Archana S Nagaraja, Robert L Dood, Guillermo Armaiz-Pena, Yu Kang, Sherry Y Wu, Nicholas B Jennings

JCI Insight· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype.
Shaolin Ma, Michael H McGuire, Lingegowda S Mangala, Sanghoon Lee, Elaine Stur, Nicholas B Jennings

Cell Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability.
Hailing Yang, Weiqun Mao, Cristian Rodriguez-Aguayo, Lingegowda S Mangala, Geoffrey Bartholomeusz, Nicholas B Jennings

Clin Cancer Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers.
Hailing Yang, Zhang Shu, Yongying Jiang, Weiqun Mao, Lan Pang, Nicholas B Jennings

Clin Cancer Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair.
Yun-Yong Park, Sung Yun Jung, Nicholas B Jennings, Cristian Rodriguez-Aguayo, Guang Peng

Carcinogenesis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Focal Adhesion Kinase Targeting Using Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy.
Jyotsnabaran Halder, Aparna A Kamat, Charles N Landen, Liz Y Han, Susan K Lutgendorf, Nicholas B Jennings

Clin Cancer Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability.
Hailing Yang, Weiqun Mao, Cristian Rodriguez-Aguayo, Lingegowda S Mangala, Geoffrey Bartholomeusz, Nicholas B Jennings

Clin Cancer Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stress effects on FosB and interleukin-8 ()-driven ovarian cancer growth and metastasis.
Mian M K Shahzad, Jesusa M Arevalo, Guillermo N Armaiz-Pena, Chunhua Lu, Rebecca L Stone, Nicholas B Jennings

J Biol Chem· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis